PerkinElmer In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More News items for the week of Jan. 23, 2023. PerkinElmer Becoming Pure Play Dx, Life Science Firm, Spurred on by COVID Innovations At the JP Morgan conference, the firm's CEO said that it chose to divest its applied, food, and enterprise businesses due to innovations it achieved during the pandemic. Molecular SMA Testing in Newborns on the Rise as Countries Add Screening Programs Premium State labs and commercial companies see rising spinal muscular atrophy test volumes as screening programs launch in US states and European countries, among others. Cowen Upgrades PerkinElmer Stock to Outperform Analyst Max Masucci said the firm is expected to generate at least $3.21 billion in COVID-19-related revenues, while he lowered the stock price target to $164 per share. In Brief This Week: 908 Devices, Natera, PerkinElmer, Hologic, Hamilton, BioFluidiX, More News items for the week of Nov. 14, 2022 Nov 14, 2022 PerkinElmer Nabs Authorization for Molecular SCID/SMA Test in Newborns Nov 8, 2022 PerkinElmer Q3 Revenues Drop 17 Percent, Diagnostics Off 39 Percent Oct 28, 2022 In Brief This Week: OpGen, MDxHealth, Dante Genomics, More Oct 21, 2022 In Brief This Week: Pacific Biosciences, Pierian, PerkinElmer, Ginkgo Bioworks, More Oct 20, 2022 Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court Premium Oct 19, 2022 MDIC, Horizon Discovery Partner on Reference Samples for NGS-Based Cancer Tests Aug 22, 2022 MDIC Launches Initiative to Improve Accuracy of Next-Generation Sequencing-Based Cancer Diagnostics Aug 19, 2022 People in the News at 23andMe, PerkinElmer, Capsulomics, More Aug 1, 2022 PerkinElmer Focusing on Life Sciences, Diagnostics as it Divests Other Businesses Premium Jul 29, 2022 In Brief This Week: Genetic Signatures, SEngine Precision Medicine, Inex Innovate, More Jul 20, 2022 UBS Initiates Coverage on QuidelOrtho, Waters, PerkinElmer, Hologic, Agilent Technologies Jul 5, 2022 Evercore ISI Downgrades PerkinElmer Shares to In Line Jun 28, 2022 PerkinElmer, Siemens Healthineers, SummerBio Lay Off Workers, Close Facilities May 20, 2022 New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More May 3, 2022 PerkinElmer Q1 Revenues Shrink 4 Percent, Beat Wall Street Estimate Apr 29, 2022 In Brief This Week: Natera, Caris Life Sciences, Fulgent Genetics, Castle Biosciences, More Apr 21, 2022 Industry Testing Alliance Seeks to Broaden Use of Cardiogenomic NGS Panels Premium Apr 8, 2022 In Brief This Week: Cardea Bio, Proof Diagnostics, Ginkgo Bioworks, Twist Bioscience, More Apr 6, 2022 As COVID-19 Sales Retreat, Diagnostic Firms Turn Attention to Core Businesses Premium Mar 22, 2022 Cardiology Genomic Testing Alliance Formed by Five Companies Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.